<DOC>
	<DOCNO>NCT02871986</DOCNO>
	<brief_summary>The investigator wish explore variability uterine , breast bone outcome marker surrogates assess adequacy exogenous oestrogen replacement individual hypogonadism .</brief_summary>
	<brief_title>Pubertal Induction Individuals With Hypogonadism</brief_title>
	<detailed_description>The investigator invite individual hypogonadism require pubertal induction participate study . The participant receive conventional routine oestrogen replacement form transdermal patch . The participant review every 2 month total 8 month document uterine , breast bone assessment . This complete use variety tool . After 4 month , participant receive incremental increase oestrogen dose .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Amenorrhea</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Hypopituitarism</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>1 . Have diagnosis hypogonadism ( Turner 's syndrome , hypogonadotrophic hypogonadism , primary ovarian insufficiency , hypopituitarism , hypothalamic amenorrhoea , transgender ) 2 . ≥ 10 year age 3 . Oestrogen naïve i.e . prior commencement oestrogen treatment 4 . Breast Tanner stage ≤ 2 1 . Previous oncology treatment 2 . Primary amenorrhoea secondary chronic medical comorbidity 3 . PCOS diagnosis</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>